The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pelletier Saundra L since 2018.
This trader's CIK number is 1251371.
At the time of last reporting, Pelletier Saundra L was the Chief Executive Officer of Evofem Biosciences, Inc.. (stock ticker symbol EVFM).
Also see all insider trading activities at Evofem Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | TCON | 6,545 | $25,001 | 0 | $0 | 0 | $0 |
| 2020 | TCON | 5,500 | $11,209 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | EVFM | 141,000 | $49,773 | 0 | $0 | 0 | $0 |
| 2021 | EVFM | 230,249 | $205,292 | 0 | $0 | 0 | $0 |
| 2020 | EVFM | 0 | $0 | 132,500 | $459,685 | 0 | $0 |
| 2019 | EVFM | 0 | $0 | 30,000 | $206,100 | 0 | $0 |
| 2018 | EVFM | 10,000 | $21,100 | 0 | $0 | 0 | $0 |
1. Tracon Pharmaceuticals, Inc. (TCON)
2. Evofem Biosciences, Inc. (EVFM)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-07-26 | TCON | Buy | 6,545 | 3.82 | 25,001 |
| 2020-06-15 | TCON | Buy | 3,000 | 2.07 | 6,209 |
| 2020-06-11 | TCON | Buy | 2,500 | 2.00 | 5,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-27 | EVFM | Buy | 141,000 | .35 | 49,773 |
| 2021-12-20 | EVFM | Buy | 135,000 | .38 | 50,625 |
| 2021-06-10 | EVFM | Buy | 50,000 | 1.03 | 51,500 |
| 2021-03-09 | EVFM | Buy | 45,249 | 2.28 | 103,167 |
| 2020-09-08 | EVFM | Sale | 122,500 | 3.26 | 399,350 |
| 2020-01-13 | EVFM | Sale | 3,295 | 6.00 | 19,770 |
| 2020-01-02 | EVFM | Sale | 6,705 | 6.05 | 40,565 |
| 2019-12-02 | EVFM | Sale | 20,000 | 7.30 | 146,000 |
| 2019-11-21 | EVFM | Sale | 10,000 | 6.01 | 60,100 |
| 2018-08-10 | EVFM | Buy | 10,000 | 2.11 | 21,100 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pelletier Saundra L (Chief Executive Officer of Evofem Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.